Medpace Holdings, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	707.3M	706.6M	708.5M	659.9M	603.3M	558.6M	536.6M	533.3M
Cost of Goods Sold	505.7M	510.3M	503.1M	463.0M	423.3M	380.2M	358.3M	364.3M
Gross Profit	201.6M	196.3M	205.3M	196.9M	180.0M	178.3M	178.3M	169.0M
R&D Expenses	0	0	0	0	0	0	0	0
Operating Expenses	54.8M	54.8M	52.0M	55.1M	53.7M	64.8M	52.9M	56.7M
Operating Income	146.8M	141.5M	153.3M	141.8M	126.3M	113.5M	125.4M	112.3M
Other Income / Gains	4.8M	6.1M	3.6M	1.0M	-1.8M	4.6M	8.5M	6.5M
Net Income	121.4M	123.9M	135.1M	111.1M	90.3M	114.6M	117.0M	96.4M
EPS (Diluted)	4.31	4.35	4.78	3.95	3.16	3.77	3.78	3.11
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.285	0.278	0.29	0.298	0.298	0.319	0.332	0.317
General And Administrative Expenses	0	0	0	0	0	0	43.9M	0
Selling And Marketing Expenses	0	0	0	0	0	0	1.5M	0
Selling General And Administrative Expenses	48.1M	47.9M	44.9M	48.1M	46.7M	57.9M	45.4M	49.2M
Other Expenses	6.7M	6.9M	7.1M	7.0M	7.0M	6.9M	7.5M	7.5M
Cost And Expenses	560.5M	565.1M	555.2M	518.1M	477.0M	445.0M	411.2M	421.0M
Interest Income	-5.1M	5.1M	0	1.5M	1.1M	6.5M	7.9M	7.5M
Interest Expense	0	0	0	0	0	0	0	0
Depreciation And Amortization	-6.9M	6.9M	7.1M	7.0M	7.0M	6.9M	7.5M	7.5M
Ebitda	133.8M	154.5M	164.0M	149.9M	131.6M	125.1M	141.4M	126.3M
Ebitdaratio	0.189	0.219	0.231	0.227	0.218	0.224	0.263	0.237
Operating Income Ratio	0.208	0.20	0.216	0.215	0.209	0.203	0.234	0.211
Income Before Tax	151.7M	147.6M	156.8M	142.8M	124.5M	118.2M	133.9M	118.8M
Income Before Tax Ratio	0.214	0.209	0.221	0.216	0.206	0.212	0.25	0.223
Income Tax Expense	30.3M	23.7M	21.7M	31.7M	34.3M	3.6M	16.9M	22.4M
Net Income Ratio	0.172	0.175	0.191	0.168	0.15	0.205	0.218	0.181
Epsdiluted	4.25	4.28	4.67	3.87	3.10	3.67	3.67	3.01
Weighted Average Shs Out	28.3M	28.4M	28.3M	29.0M	29.5M	30.4M	30.9M	31.0M
Weighted Average Shs Out Dil	28.8M	29.0M	29.0M	29.7M	30.2M	31.2M	32.0M	32.1M